Vitamin K and vascular calcification

Vitamin-Binding Proteins: Functional Consequences

Volumn , Issue , 2013, Pages 157-168

  Palaniswamy, Chandrasekar ^a   Aronow, Wilbert S ^a   Khanagavi, Jagadish ^a   Sekhri, Arunabh ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85054752112     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b15313     Document Type: Chapter

References (52)

1. Dam H, Schonheyder F. A deficiency disease in chicks resembling scurvy, Biochem J 1934; 28: 1355-1359.
2. Doisy EA, Binkley SB, Thayer SA, McKee RW. Vitamin K, Science 1940; 91: 58-62.
3. Palaniswamy C, Sekhri A, Aronow WS, Kalra A, Peterson SJ. Association of warfarin use with valvular and vascular calcification: A review, Clin Cardiol 2011; 34: 74-81.
4. Rifkin RD, Parisi AF, Folland E. Coronary calcification in the diagnosis of coronary artery disease, Am J Cardiol 1979; 44: 141-147.
5. Friedman SA, Novack S, Thomson GE. Arterial calcification and gangrene in uremia, N Engl J Med 1969; 280: 1392-1394.
6. Massry SG, Gordon A, Coburn JW, et al. Vascular calcification and peripheral necrosis in a renal transplant recipient. Reversal of lesions following subtotal parathyroidectomy, Am J Med 1970; 49: 416-422.
7. Schurgers LJ, Dissel PE, Spronk HM, et al. Role of vitamin K and vitamin K-dependent proteins in vascular calcification, Z Kardiol 2001;90 Suppl 3:57-63.
8. Lehto S, Niskanen L, Suhonen M, Ronnemaa T, Laakso M. Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus, Arterioscler Thromb Vasc Biol 1996; 16: 978-983.
9. Price PA, Urist MR, Otawara Y. Matrix Gla protein, a new gamma-carboxyglutamic acid-containing protein which is associated with the organic matrix of bone, Biochem Biophys Res Commun 1983; 117: 765-771.
10. Howe AM, Webster WS. The warfarin embryopathy: A rat model showing maxillonasal hypoplasia and other skeletal disturbances, Teratology 1992; 46: 379-390.
11. Hale JE, Fraser JD, Price PA. The identification of matrix Gla protein in cartilage, J Biol Chem 1988; 263: 5820-5824.
12. Luo G, Ducy P, McKee MD, et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein, Nature 1997; 386: 78-81.
13. Spronk HM, Soute BA, Schurgers LJ, et al. Matrix Gla protein accumulates at the border of regions of calcification and normal tissue in the media of the arterial vessel wall, Biochem Biophys Res Commun 2001; 289: 485-490.
14. Sweatt A, Sane DC, Hutson SM, Wallin R. Matrix Gla protein (MGP) and bone morphogenetic protein-2 in aortic calcified lesions of aging rats, J Thromb Haemost 2003; 1: 178-185.
15. Nishimoto SK, Nishimoto M. Matrix Gla protein C-terminal region binds to vitronectin. Co-localization suggests binding occurs during tissue development, Matrix Biol 2005; 24: 353-361.
16. Price PA, Chan WS, Jolson DM, Williamson MK. The elastic lamellae of devitalized arteries calcify when incubated in serum: Evidence for a serum calcification factor, Arterioscler Thromb Vasc Biol 2006; 26: 1079-1085.
17. Reynolds JL, Joannides AJ, Skepper JN, et al. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: A potential mechanism for accelerated vascular calcification in ESRD, J Am Soc Nephrol 2004; 15: 2857-2867.
18. Strebel RF, Girerd RJ, Wagner BM. Cardiovascular calcification in rats with hypervitaminosis A, Arch Pathol 1969; 87: 290-297.
19. Cancela ML, Price PA. Retinoic acid induces matrix Gla protein gene expression in human cells, Endocrinology 1992; 130: 102-108.
20. Farzaneh-Far A, Proudfoot D, Weissberg PL, Shanahan CM. Matrix Gla protein is regulated by a mechanism functionally related to the calcium-sensing receptor, Biochem Biophys Res Commun 2000; 277: 736-740.
21. Munroe PB, Olgunturk RO, Fryns JP, et al. Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome, Nat Genet 1999; 21: 142-144.
22. Hur DJ, Raymond GV, Kahler SG, Riegert-Johnson DL, Cohen BA, Boyadjiev SA. A novel MGP mutation in a consanguineous family: Review of the clinical and molecular characteristics of Keutel syndrome, Am J Med Genet A 2005; 135: 36-40.
23. Howe AM, Webster WS. Warfarin exposure and calcification of the arterial system in the rat, Int J Exp Pathol 2000; 81: 51-56.
24. Price PA, Faus SA, Williamson MK. Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves, Arterioscler Thromb Vasc Biol 1998; 18: 1400-1407.
25. Price PA, Faus SA, Williamson MK. Warfarin-induced artery calcification is accelerated by growth and vitamin D, Arterioscler Thromb Vasc Biol 2000; 20: 317-327.
26. Coates T, Kirkland GS, Dymock RB, et al. Cutaneous necrosis from calcific uremic arteriolopathy, Am J Kidney Dis 1998; 32: 384-391.
27. Schori TR, Stungis GE. Long-term warfarin treatment may induce arterial calcification in humans: Case report, Clin Invest Med 2004; 27: 107-109.
28. Verdalles Guzman U, de la Cueva P, Verde E, et al. Calciphylaxis: Fatal complication of cardiometabolic syndrome in patients with end stage kidney disease, Nefrologia 2008; 28: 32-36.
29. Villines TC, O’Malley PG, Feuerstein IM, Thomas S, Taylor AJ. Does prolonged warfarin exposure potentiate coronary calcification in humans? Results of the warfarin and coronary calcification study, Calcif Tissue Int 2009; 85: 494-500.
30. Schurgers LJ, Aebert H, Vermeer C, Bultmann B, Janzen J. Oral anticoagulant treatment: Friend or foe in cardiovascular disease? Blood 2004; 104: 3231-3232.
31. Koos R, Mahnken AH, Muhlenbruch G, et al. Relation of oral anticoagulation to cardiac valvular and coronary calcium assessed by multislice spiral computed tomography, Am J Cardiol 2005; 96: 747-749.
32. Koos R, Krueger T, Westenfeld R, et al. Relation of circulating Matrix Gla-Protein and anticoagulation status in patients with aortic valve calcification, Thromb Haemost 2009; 101: 706-713.
33. Holden RM, Sanfilippo AS, Hopman WM, Zimmerman D, Garland JS, Morton AR. Warfarin and aortic valve calcification in hemodialysis patients, J Nephrol 2007; 20: 417-422.
34. Goodman WG, Goldin J, Kuizon BD, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis, N Engl J Med 2000; 342: 1478-1483.
35. Pilkey RM, Morton AR, Boffa MB, et al. Subclinical vitamin K deficiency in hemodialysis patients, Am J Kidney Dis 2007; 49: 432-439.
36. Yamamoto K, Yamamoto H, Yoshida K, et al. Prognostic factors for progression of early-and late-stage calcific aortic valve disease in Japanese: The Japanese Aortic Stenosis Study (JASS) Retrospective Analysis, Hypertens Res 2010; 33: 269-274.
37. Lerner RG, Aronow WS, Sekhri A, et al. Warfarin use and the risk of valvular calcification, J Thromb Haemost 2009; 7: 2023-2027.
38. Schurgers LJ, Spronk HM, Soute BA, Schiffers PM, DeMey JG, Vermeer C. Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats, Blood 2007; 109: 2823-2831.
39. Proudfoot D, Davies JD, Skepper JN, Weissberg PL, Shanahan CM. Acetylated low-density lipoprotein stimulates human vascular smooth muscle cell calcification by promoting osteoblastic differentiation and inhibiting phagocytosis, Circulation 2002; 106: 3044-3050.
40. Spronk HM, Soute BA, Schurgers LJ, Thijssen HH, De Mey JG, Vermeer C. Tissue-specific utilization of menaquinone-4 results in the prevention of arterial calcification in warfarin-treated rats, J Vasc Res 2003; 40: 531-537.
41. Wallin R, Schurgers L, Wajih N. Effects of the blood coagulation vitamin K as an inhibitor of arterial calcification, Thromb Res 2008; 122: 411-417.
42. Geleijnse JM, Vermeer C, Grobbee DE, et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: The Rotterdam Study, J Nutr 2004; 134: 3100-3105.
43. Braam LA, Hoeks AP, Brouns F, Hamulyak K, Gerichhausen MJ, Vermeer C. Beneficial effects of vitamins D and K on the elastic properties of the vessel wall in postmenopausal women: A follow-up study, Thromb Haemost 2004; 91: 373-380.
44. Banerjee C, Woller SC, Holm JR, Stevens SM, Lahey MJ. Atypical calciphylaxis in a patient receiving warfarin then resolving with cessation of warfarin and application of hyperbaric oxygen therapy, Clin Appl Thromb Hemost 2010; 16: 345-350.
45. Palaniswamy C, Selvaraj DR, Selvaraj T, Sukhija R. Mechanisms underlying pleiotropic effects of statins, Am J Ther 2010; 17: 75-78.
46. Kizu A, Shioi A, Jono S, Koyama H, Okuno Y, Nishizawa Y. Statins inhibit in vitro calcification of human vascular smooth muscle cells induced by inflammatory mediators, J Cell Biochem 2004; 93: 1011-1019.
47. Li H, Tao HR, Hu T, et al. Atorvastatin reduces calcification in rat arteries and vascular smooth muscle cells, Basic Clin Pharmacol Toxicol 2010; 107: 798-802.
48. Yang S, Zhou JZ, Chen YH. Effects of atorvastatin calcium on osteopontin in renovascular hypertensive rats, Beijing Da Xue Xue Bao 2010; 42: 147-150.
49. Francis MD, Russell RG, Fleisch H. Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo, Science 1969; 165: 1264-1266.
50. Price PA, Faus SA, Williamson MK. Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption, Arterioscler Thromb Vasc Biol 2001; 21: 817-824.
51. Toussaint ND, Lau KK, Strauss BJ, Polkinghorne KR, Kerr PG. Effect of alendronate on vascular calcification in CKD stages 3 and 4: A pilot randomized controlled trial, Am J Kidney Dis 2010; 56: 57-68.
52. Price PA, June HH, Buckley JR, Williamson MK. Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D, Arterioscler Thromb Vasc Biol 2001; 21: 1610-1616.